Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lung Diseases × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Pemetrexed 3 Carboplatin 3 pralsetinib 2 pembrolizumab 2 sotorasib 1 sitravatinib 1 selpercatinib 1 patritumab 1 osimertinib 1 demcizumab 1 cobimetinib 1 atezolizumab 1 aflibercept 1 Tyrosine Kinase Inhibitors 1 Paclitaxel 1 Nivolumab 1 Ipilimumab 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Dasatinib 1 Cisplatin 1 Bevacizumab 1 Afatinib 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡